APO Research

APO RESEARCH · REPORT

Exosome Service

Selected research

Industry Growth & Trends

Global Exosome Service Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Exosome Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Exosome Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Exosome Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exosome Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Exosome Service market include LipExoGen Biotech, Creative Biostructure, Immunostep Biotech, AMSBIO, Frontage Labs, EVerZom, System Biosicences (SBI), Exosome Diagnostics and Creative Bioarray, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Exosome Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Exosome Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Exosome Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Exosome Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Exosome Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Exosome Service Market by Company

LipExoGen Biotech

Creative Biostructure

Immunostep Biotech

AMSBIO

Frontage Labs

EVerZom

System Biosicences (SBI)

Exosome Diagnostics

Creative Bioarray

Exosomics

Creative Proteomics

RoosterBio

Clara Biotech

Luminous BioSciences

Capital Biosciences

Anazao

Alpha Nano Tech

NCELL

Wayen Biotechnologies (Shanghai)

Shanghai Yanjiang Biotechnology

Exosome Service Segment by Type

Exosome Isolation

Exosome Identification

Exosome Analysis

Other

Exosome Service Segment by Application

Medicine

Biological

Other

Exosome Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exosome Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Exosome Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Exosome Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Exosome Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Exosome Service Market Share by Region (2021-2026) Table 4. Global Exosome Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Exosome Service Market Share by Region (2027-2032) Table 6. Global Exosome Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Exosome Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Exosome Service Market Size Share by Type (2021-2026) Table 9. Global Exosome Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Exosome Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Exosome Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Exosome Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Exosome Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Exosome Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Exosome Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Exosome Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Exosome Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Exosome Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Exosome Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Exosome Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Exosome Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Exosome Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Exosome Service Market Size Share by Application (2021-2026) Table 24. Global Exosome Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Exosome Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Exosome Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Exosome Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Exosome Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Exosome Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Exosome Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Exosome Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Exosome Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Exosome Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Exosome Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Exosome Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Exosome Service Industry Trends Table 37. Exosome Service Industry Drivers Table 38. Exosome Service Industry Opportunities and Challenges Table 39. Exosome Service Industry Restraints Table 40. Global Exosome Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Exosome Service Revenue Market Share by Company (2021-2026) Table 42. Global Exosome Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Exosome Service Key Company Headquarters & Area Served Table 44. Global Exosome Service Company, Product Type & Application Table 45. Global Exosome Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Exosome Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. LipExoGen Biotech Company Information Table 49. LipExoGen Biotech Business Overview Table 50. LipExoGen Biotech Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. LipExoGen Biotech Exosome Service Product Portfolio Table 52. LipExoGen Biotech Recent Development Table 53. Creative Biostructure Company Information Table 54. Creative Biostructure Business Overview Table 55. Creative Biostructure Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Creative Biostructure Exosome Service Product Portfolio Table 57. Creative Biostructure Recent Development Table 58. Immunostep Biotech Company Information Table 59. Immunostep Biotech Business Overview Table 60. Immunostep Biotech Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Immunostep Biotech Exosome Service Product Portfolio Table 62. Immunostep Biotech Recent Development Table 63. AMSBIO Company Information Table 64. AMSBIO Business Overview Table 65. AMSBIO Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. AMSBIO Exosome Service Product Portfolio Table 67. AMSBIO Recent Development Table 68. Frontage Labs Company Information Table 69. Frontage Labs Business Overview Table 70. Frontage Labs Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Frontage Labs Exosome Service Product Portfolio Table 72. Frontage Labs Recent Development Table 73. EVerZom Company Information Table 74. EVerZom Business Overview Table 75. EVerZom Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. EVerZom Exosome Service Product Portfolio Table 77. EVerZom Recent Development Table 78. System Biosicences (SBI) Company Information Table 79. System Biosicences (SBI) Business Overview Table 80. System Biosicences (SBI) Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. System Biosicences (SBI) Exosome Service Product Portfolio Table 82. System Biosicences (SBI) Recent Development Table 83. Exosome Diagnostics Company Information Table 84. Exosome Diagnostics Business Overview Table 85. Exosome Diagnostics Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Exosome Diagnostics Exosome Service Product Portfolio Table 87. Exosome Diagnostics Recent Development Table 88. Creative Bioarray Company Information Table 89. Creative Bioarray Business Overview Table 90. Creative Bioarray Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Creative Bioarray Exosome Service Product Portfolio Table 92. Creative Bioarray Recent Development Table 93. Exosomics Company Information Table 94. Exosomics Business Overview Table 95. Exosomics Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Exosomics Exosome Service Product Portfolio Table 97. Exosomics Recent Development Table 98. Creative Proteomics Company Information Table 99. Creative Proteomics Business Overview Table 100. Creative Proteomics Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Creative Proteomics Exosome Service Product Portfolio Table 102. Creative Proteomics Recent Development Table 103. RoosterBio Company Information Table 104. RoosterBio Business Overview Table 105. RoosterBio Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. RoosterBio Exosome Service Product Portfolio Table 107. RoosterBio Recent Development Table 108. Clara Biotech Company Information Table 109. Clara Biotech Business Overview Table 110. Clara Biotech Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Clara Biotech Exosome Service Product Portfolio Table 112. Clara Biotech Recent Development Table 113. Luminous BioSciences Company Information Table 114. Luminous BioSciences Business Overview Table 115. Luminous BioSciences Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Luminous BioSciences Exosome Service Product Portfolio Table 117. Luminous BioSciences Recent Development Table 118. Capital Biosciences Company Information Table 119. Capital Biosciences Business Overview Table 120. Capital Biosciences Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Capital Biosciences Exosome Service Product Portfolio Table 122. Capital Biosciences Recent Development Table 123. Anazao Company Information Table 124. Anazao Business Overview Table 125. Anazao Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Anazao Exosome Service Product Portfolio Table 127. Anazao Recent Development Table 128. Alpha Nano Tech Company Information Table 129. Alpha Nano Tech Business Overview Table 130. Alpha Nano Tech Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Alpha Nano Tech Exosome Service Product Portfolio Table 132. Alpha Nano Tech Recent Development Table 133. NCELL Company Information Table 134. NCELL Business Overview Table 135. NCELL Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. NCELL Exosome Service Product Portfolio Table 137. NCELL Recent Development Table 138. Wayen Biotechnologies (Shanghai) Company Information Table 139. Wayen Biotechnologies (Shanghai) Business Overview Table 140. Wayen Biotechnologies (Shanghai) Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Wayen Biotechnologies (Shanghai) Exosome Service Product Portfolio Table 142. Wayen Biotechnologies (Shanghai) Recent Development Table 143. Shanghai Yanjiang Biotechnology Company Information Table 144. Shanghai Yanjiang Biotechnology Business Overview Table 145. Shanghai Yanjiang Biotechnology Exosome Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Shanghai Yanjiang Biotechnology Exosome Service Product Portfolio Table 147. Shanghai Yanjiang Biotechnology Recent Development Table 148. North America Exosome Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Exosome Service Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Exosome Service Market Share by Country (2021-2026) Table 151. North America Exosome Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Exosome Service Market Share Forecast by Country (2027-2032) Table 153. Europe Exosome Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Exosome Service Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Exosome Service Market Share by Country (2021-2026) Table 156. Europe Exosome Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Exosome Service Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Exosome Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Exosome Service Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Exosome Service Market Share by Country (2021-2026) Table 161. Asia-Pacific Exosome Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Exosome Service Market Share Forecast by Country (2027-2032) Table 163. Latin America Exosome Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Exosome Service Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Exosome Service Market Share by Country (2021-2026) Table 166. Latin America Exosome Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Exosome Service Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Exosome Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Exosome Service Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Exosome Service Market Share by Country (2021-2026) Table 171. Middle East & Africa Exosome Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Exosome Service Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Exosome Service Product Image Figure 3. Global Exosome Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Exosome Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Exosome Service Market Share by Region: 2025 VS 2032 Figure 6. Global Exosome Service Market Share by Region (2021-2032) Figure 7. North America Exosome Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Exosome Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Exosome Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Exosome Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Exosome Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Exosome Isolation Image Figure 13. Global Exosome Isolation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Exosome Identification Image Figure 15. Global Exosome Identification Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Exosome Analysis Image Figure 17. Global Exosome Analysis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Exosome Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Exosome Service Market Share by Type 2025 VS 2032 Figure 22. North America Exosome Service Market Size Share by Type (2021-2032) Figure 23. Europe Exosome Service Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Exosome Service Market Size Share by Type (2021-2032) Figure 25. Latin America Exosome Service Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Exosome Service Market Size Share by Type (2021-2032) Figure 27. Medicine Image Figure 28. Global Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Biological Image Figure 30. Global Biological Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Exosome Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Exosome Service Market Share by Application 2025 VS 2032 Figure 35. North America Exosome Service Market Size Share by Application (2021-2032) Figure 36. Europe Exosome Service Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Exosome Service Market Size Share by Application (2021-2032) Figure 38. Latin America Exosome Service Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Exosome Service Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Exosome Service Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Exosome Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Exosome Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Exosome Service Market Share by Country (2021-2032) Figure 45. Europe Exosome Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Exosome Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Exosome Service Market Share by Country (2021-2032) Figure 48. Asia-Pacific Exosome Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Exosome Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Exosome Service Market Share by Country (2021-2032) Figure 51. Latin America Exosome Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Exosome Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Exosome Service Market Share by Country (2021-2032) Figure 54. Middle East & Africa Exosome Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Exosome Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Exosome Service Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Exosome Isolation
  • Exosome Identification
  • Exosome Analysis
  • Other
Applications
  • Medicine
  • Biological
  • Other
Companies covered
  • LipExoGen Biotech
  • Creative Biostructure
  • Immunostep Biotech
  • AMSBIO
  • Frontage Labs
  • EVerZom
  • System Biosicences (SBI)
  • Exosome Diagnostics
  • Creative Bioarray
  • Exosomics
  • Creative Proteomics
  • RoosterBio
  • Clara Biotech
  • Luminous BioSciences
  • Capital Biosciences
  • Anazao
  • Alpha Nano Tech
  • NCELL
  • Wayen Biotechnologies (Shanghai)
  • Shanghai Yanjiang Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Exosome Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Exosome Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Exosome Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Exosome Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Exosome Service Market Size (2021-2032)
  8. 1.5.1 North America Exosome Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Exosome Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Exosome Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Exosome Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Exosome Service Market Size Growth Rate (2021-2032)
2 Exosome Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Exosome Isolation
  3. 2.1.2 Exosome Identification
  4. 2.1.3 Exosome Analysis
  5. 2.1.4 Other
  6. 2.2 Global Exosome Service Market Size by Type
  7. 2.2.1 Global Exosome Service Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Exosome Service Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Exosome Service Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Exosome Service Market Size by Regions
  11. 2.3.1 North America Exosome Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Exosome Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Exosome Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Exosome Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Exosome Service Market Size Breakdown by Type (2021-2026)
3 Exosome Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medicine
  3. 3.1.2 Biological
  4. 3.1.3 Other
  5. 3.2 Global Exosome Service Market Size by Application
  6. 3.2.1 Global Exosome Service Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Exosome Service Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Exosome Service Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Exosome Service Market Size by Regions
  10. 3.3.1 North America Exosome Service Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Exosome Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Exosome Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Exosome Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Exosome Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Exosome Service Industry Trends
  2. 4.2 Exosome Service Industry Drivers
  3. 4.3 Exosome Service Industry Opportunities and Challenges
  4. 4.4 Exosome Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Exosome Service Revenue (2021-2026)
  2. 5.2 Global Exosome Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Exosome Service Key Company Headquarters & Area Served
  4. 5.4 Global Exosome Service Company, Product Type & Application
  5. 5.5 Global Exosome Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Exosome Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Exosome Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Exosome Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 LipExoGen Biotech
  2. 6.1.1 LipExoGen Biotech Company Information
  3. 6.1.2 LipExoGen Biotech Business Overview
  4. 6.1.3 LipExoGen Biotech Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 LipExoGen Biotech Exosome Service Product Portfolio
  6. 6.1.5 LipExoGen Biotech Recent Developments
  7. 6.2 Creative Biostructure
  8. 6.2.1 Creative Biostructure Company Information
  9. 6.2.2 Creative Biostructure Business Overview
  10. 6.2.3 Creative Biostructure Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Creative Biostructure Exosome Service Product Portfolio
  12. 6.2.5 Creative Biostructure Recent Developments
  13. 6.3 Immunostep Biotech
  14. 6.3.1 Immunostep Biotech Company Information
  15. 6.3.2 Immunostep Biotech Business Overview
  16. 6.3.3 Immunostep Biotech Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Immunostep Biotech Exosome Service Product Portfolio
  18. 6.3.5 Immunostep Biotech Recent Developments
  19. 6.4 AMSBIO
  20. 6.4.1 AMSBIO Company Information
  21. 6.4.2 AMSBIO Business Overview
  22. 6.4.3 AMSBIO Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 AMSBIO Exosome Service Product Portfolio
  24. 6.4.5 AMSBIO Recent Developments
  25. 6.5 Frontage Labs
  26. 6.5.1 Frontage Labs Company Information
  27. 6.5.2 Frontage Labs Business Overview
  28. 6.5.3 Frontage Labs Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Frontage Labs Exosome Service Product Portfolio
  30. 6.5.5 Frontage Labs Recent Developments
  31. 6.6 EVerZom
  32. 6.6.1 EVerZom Company Information
  33. 6.6.2 EVerZom Business Overview
  34. 6.6.3 EVerZom Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 EVerZom Exosome Service Product Portfolio
  36. 6.6.5 EVerZom Recent Developments
  37. 6.7 System Biosicences (SBI)
  38. 6.7.1 System Biosicences (SBI) Company Information
  39. 6.7.2 System Biosicences (SBI) Business Overview
  40. 6.7.3 System Biosicences (SBI) Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 System Biosicences (SBI) Exosome Service Product Portfolio
  42. 6.7.5 System Biosicences (SBI) Recent Developments
  43. 6.8 Exosome Diagnostics
  44. 6.8.1 Exosome Diagnostics Company Information
  45. 6.8.2 Exosome Diagnostics Business Overview
  46. 6.8.3 Exosome Diagnostics Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Exosome Diagnostics Exosome Service Product Portfolio
  48. 6.8.5 Exosome Diagnostics Recent Developments
  49. 6.9 Creative Bioarray
  50. 6.9.1 Creative Bioarray Company Information
  51. 6.9.2 Creative Bioarray Business Overview
  52. 6.9.3 Creative Bioarray Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Creative Bioarray Exosome Service Product Portfolio
  54. 6.9.5 Creative Bioarray Recent Developments
  55. 6.10 Exosomics
  56. 6.10.1 Exosomics Company Information
  57. 6.10.2 Exosomics Business Overview
  58. 6.10.3 Exosomics Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Exosomics Exosome Service Product Portfolio
  60. 6.10.5 Exosomics Recent Developments
  61. 6.11 Creative Proteomics
  62. 6.11.1 Creative Proteomics Company Information
  63. 6.11.2 Creative Proteomics Business Overview
  64. 6.11.3 Creative Proteomics Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Creative Proteomics Exosome Service Product Portfolio
  66. 6.11.5 Creative Proteomics Recent Developments
  67. 6.12 RoosterBio
  68. 6.12.1 RoosterBio Company Information
  69. 6.12.2 RoosterBio Business Overview
  70. 6.12.3 RoosterBio Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 RoosterBio Exosome Service Product Portfolio
  72. 6.12.5 RoosterBio Recent Developments
  73. 6.13 Clara Biotech
  74. 6.13.1 Clara Biotech Company Information
  75. 6.13.2 Clara Biotech Business Overview
  76. 6.13.3 Clara Biotech Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Clara Biotech Exosome Service Product Portfolio
  78. 6.13.5 Clara Biotech Recent Developments
  79. 6.14 Luminous BioSciences
  80. 6.14.1 Luminous BioSciences Company Information
  81. 6.14.2 Luminous BioSciences Business Overview
  82. 6.14.3 Luminous BioSciences Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Luminous BioSciences Exosome Service Product Portfolio
  84. 6.14.5 Luminous BioSciences Recent Developments
  85. 6.15 Capital Biosciences
  86. 6.15.1 Capital Biosciences Company Information
  87. 6.15.2 Capital Biosciences Business Overview
  88. 6.15.3 Capital Biosciences Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Capital Biosciences Exosome Service Product Portfolio
  90. 6.15.5 Capital Biosciences Recent Developments
  91. 6.16 Anazao
  92. 6.16.1 Anazao Company Information
  93. 6.16.2 Anazao Business Overview
  94. 6.16.3 Anazao Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Anazao Exosome Service Product Portfolio
  96. 6.16.5 Anazao Recent Developments
  97. 6.17 Alpha Nano Tech
  98. 6.17.1 Alpha Nano Tech Company Information
  99. 6.17.2 Alpha Nano Tech Business Overview
  100. 6.17.3 Alpha Nano Tech Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Alpha Nano Tech Exosome Service Product Portfolio
  102. 6.17.5 Alpha Nano Tech Recent Developments
  103. 6.18 NCELL
  104. 6.18.1 NCELL Company Information
  105. 6.18.2 NCELL Business Overview
  106. 6.18.3 NCELL Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 NCELL Exosome Service Product Portfolio
  108. 6.18.5 NCELL Recent Developments
  109. 6.19 Wayen Biotechnologies (Shanghai)
  110. 6.19.1 Wayen Biotechnologies (Shanghai) Company Information
  111. 6.19.2 Wayen Biotechnologies (Shanghai) Business Overview
  112. 6.19.3 Wayen Biotechnologies (Shanghai) Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Wayen Biotechnologies (Shanghai) Exosome Service Product Portfolio
  114. 6.19.5 Wayen Biotechnologies (Shanghai) Recent Developments
  115. 6.20 Shanghai Yanjiang Biotechnology
  116. 6.20.1 Shanghai Yanjiang Biotechnology Company Information
  117. 6.20.2 Shanghai Yanjiang Biotechnology Business Overview
  118. 6.20.3 Shanghai Yanjiang Biotechnology Exosome Service Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Shanghai Yanjiang Biotechnology Exosome Service Product Portfolio
  120. 6.20.5 Shanghai Yanjiang Biotechnology Recent Developments
7 North America
  1. 7.1 North America Exosome Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Exosome Service Market Size by Country (2021-2026)
  3. 7.3 North America Exosome Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Exosome Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Exosome Service Market Size by Country (2021-2026)
  3. 8.3 Europe Exosome Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Exosome Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Exosome Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Exosome Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Exosome Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Exosome Service Market Size by Country (2021-2026)
  3. 10.3 South America Exosome Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Exosome Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Exosome Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Exosome Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research